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• This study is designed to capture the range of constructs
researchers have used to measure NBF during recovery
of consciousness
• The research question for this review was:
“What constructs are most frequently used to assess
neurobehavioral function in adults recovering
consciousness after severe TBI?”

Results

• A scoping review examines the extent and nature of the
research, identifies gaps in the literature, and may
establish the significance of commencing a full systematic
review (Levac, Colquhoun, & O’Brien, 2010)

Most Commonly Occurring Themes Were Predicting
Outcomes and Non-Pharmacological Treatment

Most Commonly Identified Outcome Measures Were
Clinical Outcome Assessments
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• Thematic analysis focuses on different topics within a
subject and their inter-relationships by interpreting the
articles.
• Analysis used to thematically group the articles and content
extracted
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• Studies primarily focused on predicting outcomes of
patients with TBI. There were many fewer studies
describing effective treatments for these patients.

25
140

20
16
15

10
8
6

120

• The focus on predicting outcomes appears to be off
target when current classification of TBI severity and type
is blunt and treatments for severe TBI are limited.

100

80

Diversity of Outcome Measures Dilutes Evidence
Base
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• As of 2015, there is no approved drug or device to treat
TBI.
• A challenge in demonstrating the effectiveness of drugs
and devices to treat TBI is the lack of sufficiently precise
outcome assessments that are approved as federally
qualified endpoints.
- The Glasgow Coma Scale (GCS) and Glasgow
Outcomes Scale (GOS) are the most commonly-used
measures of neurobehavioral function (NBF) in TBI
clinical trials.

• FDA Federally Qualified Endpoint Measures: Roadmap
to patient-focused outcome measurement includes:
- Understanding the disease
- Conceptualizing treatment benefit
- Selecting/Developing outcome measures
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Image Adapted from Burke (2011)

• TBI initiatives are attempting to advance the state of the
science by identifying and validating clinical outcome
assessments as qualified endpoints.
- TED Initiative: https://tbiendpoints.ucsf.edu/

• Most common constructs included:
- Role of genotypes & biomarkers
- Neuro-imaging & neurophysiology
- Observed behaviors in response to sensory input
(e.g. head turning and visual fixation)

• 162 incidences of COAs were reported in 58 articles
- The majority of incidences of COAs reported were
ClinROs (n=138)

Pharmacotherapy
• Agents most often reported on included:
- Amantadine
- Progesterone
- Baclofen

• Two databases, Scopus and PubMed, were searched
using 21 search terms generated from three main
concepts: “traumatic brain injury” (n=3), “neurobehavioral
function” (n=6), and “outcomes” (n=12).
• Study inclusion criteria:
- Published within the past 5 years
- Involving adult humans (>18 years old)
- Relevant to severe TBI
- Relevant to DOC

• The most frequently reported ClinROs were:
- Glasgow Coma Scale: 29 articles
- Coma Recovery Scale-Revised: 21 articles
- Glasgow Outcome Scale or GOS-Extended: 17
articles

Connecting Mechanisms of Recovery to Treatment
and Outcomes Measurement
• Only a few articles were found related to “neural
pathways”.

Neuro-Imaging and Neurophysiology

• Understanding the mechanisms of pathology in brain
injury and neuroplasticity will likely play a critical role in
more precise diagnosis and more targeted with treatment
for these patients.

• A total of 11 different techniques were identified
- The most commonly reported included: CT, MRI, and
EEG
- Others included: DTI, IMSPECT, and PET

• There appears to be a gap in the literature regarding
precision in severe TBI diagnoses and and linking this to
brain pathology in order to design more appropriate and
effective treatments.

Biometrics and Biomarkers

Future Directions

• A total of 8 biomarkers were reported in 10 articles
- APOE e4 genotype was associated with increased
risk of worse long term functional outcome after TBI
- A10398 allele associated with slower recovery time
- Other biomarkers included: H-FABP, MAP-2, BDNF,
TNF, and ChE.

• This study identified a wide range of COAs measuring
NBF. The extent to which these assessments address the
same content domains and if some domains are poorly
addressed remains unknown.

• No ObsROs or PerfROs were found in any of the articles

• Most common constructs included relationship between
“neural pathways” and recovery of consciousness.
- Auditory network more functionally connected in
patients in a minimally conscious state
- Goal directed activity may be inhibited due to inability
to coordinate precuneus fiber tracts

• Treatments for patients with severe TBI could be
developed in parallel with studies aimed at better
understanding the brain’s pathways and response to TBI.

Other
• Other commonly identified outcomes included:
- 90-day mortality, number of medical complications,
discharge disposition

Pharmacotherapy Articles Most Often Reported on
Amantadine, Progesterone, and Baclofen

• This study found a remarkable range in the diversity of
reported COAs, biomarkers, neuroimaging and
neurophysiology techniques.
- This creates challenges in comparing results across
studies and consequently limits the translation of
knowledge into practice.
• 50 different COAs were identified but only 3 were
reported in more than 25% of the articles (GCS,
GOS/GOSE, CRS/CRS-R).
- The GCS and GOSE are relatively blunt measures of
NBF recovery and the CRS-R has no published
sensitivity to change indices.

• 50 different COAs were identified

Neural Pathways

Figure 1. Search criteria for scoping review adapted using Health
Evidence™ (2009)

Biometrics & Biomarkers

Clinical Outcome Assessments

• Most common constructs included:
- Electrical stimulation,
- Coma stimulation,
- Hypothermia,
- Familiar voice auditory stimulation, and
- Interdisciplinary care models.

Limitations

Most Frequently Reported Clinical Outcome Assessments
Were Clinician-Reported Outcomes

Search timeframe was limited to studies within the last 5
years.
Articles in the scoping review are not read to analyze bias
or the quality of the study.
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• The initial search identified 229 articles were identified
After the removal of duplicates, 211 articles were
retained and reviewed for inclusion.
• 58 met the inclusion criteria. These articles were
grouped thematically based on content related to
assessment of NBF and recovery of consciousness.
• Four themes were identified: “Predicting Outcomes”,
“Non-Pharmacology Treatment”, “Pharmacotherapy”,
and “Neural Pathways”.

• Neurobehavioral rating scales detect behavioral signs of
consciousness, while biomarkers are perceived as being • Clinical Outcomes were identified within each article and
grouped as occurrences related to “clinical outcome
more precise measures of the disease not impacted by
assessments”, biometrics and biomarkers”,
human factors
“neuroimaging and neurophysiology”, and “other”.
• COAs and biomarkers have potential to measure
treatment effect

PROs
2

Number of articles

• Four types of COAs:
- Patient reported outcome (PRO)
- Clinician-reported outcome (ClinRO) measures
- Observer-reported outcome (ObsRO) measure
- Performance outcome (PerfO) measures

Other

Predicting Outcomes

Non-Pharmacotherapy Treatment

• Clinical Outcome Assessments (COAs) are “reported”
assessments influenced by human choices, judgment, or
motivation and may provide direct of indirect evidence to
treatment benefit.

Neuroimaging &
Neurophysiology

Figure 4. Frequency of Outcome Types

Figure 2. Frequency of Themes By Article

• Approximately 10% of the 1.7 million traumatic brain
injuries (TBI) that occur each year in the US are
considered severe and result in significant disability
(CDC, 2016)

• The most frequently occurring theme was Predicting
Outcomes, followed by Non-Pharmacotherapy treatment.
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Current Literature Focuses on Predicting Outcomes
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• The scoping review methodological framework for this study
followed that of Arksey & O’Malley (2005): 1) identify the
research question, 2) identify relevant studies, select
studies, 3) chart the data, 4) collate, summarize and report
results.

Discussion

Results

Number of articles

• This scoping review aims to report the findings of current
literature examining the assessment of neurobehavioral
function and recovery along the continuum of disorders
of consciousness (DOC) from coma to full
consciousness.

Analytic Framework

Number of articles

Study Aims
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Breadth of the articles is wide rather than deep.
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Figure 3. Frequency of Articles Reporting on Drugs used as
Pharmacotherapy for Severe TBI

Figure 5. Frequency of the types of COAs found in the articles.
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